SpyGlass Pharma Inc.(SGP:US)
Market Cap$802.71M
Key Metrics
Price$24
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$223.14M
Total Assets$243.43M
Net Assets$232.36M
Total Debt$1.63M
Key Metrics
Price$24
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$223.14M
Total Assets$243.43M
Net Assets$232.36M
Total Debt$1.63M
Financials
| Name | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Mar 31, 2025 | Dec 31, 2024 |
|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | - |
Cost of Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
| $21.97M | $15.41M | $13.63M | $7.42M | - | |
| Research and Development | $10.94M | $8.54M | $7.71M | $6.05M | - |
| Selling, General, and Administrative | $11.03M | $6.87M | $5.92M | $1.37M | - |
| Other Operating Expenses | - | - | - | - | - |
Operating Income | -$21.97M | -$15.41M | -$13.63M | -$7.42M | - |
| $2.1M | $1.59M | $1.07M | -$1.4M | - | |
| Non-Operating Interest Income | $2.1M | $1.59M | $1.07M | $126K | - |
| Non-Operating Interest Expense | - | - | - | - | - |
| Other Income/Expense | - | - | $11 | -$1.53M | - |
Income Before Tax | -$19.86M | -$13.82M | -$12.56M | -$8.82M | - |
Income Tax | $0 | $0 | $0 | $0 | $0 |
Net Income | -$19.86M | -$13.82M | -$12.56M | -$8.82M | - |
Minority Interests | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - |
Net Income to Common | -$19.86M | -$13.82M | -$12.56M | -$8.82M | - |
Shares Outstanding (Basic) | 33.44M | 19.93M | - | 17.96M | - |
Shares Outstanding (Diluted) | 33.44M | 19.93M | - | 17.96M | - |
EPS (Basic) | -$0.59 | -$0.69 | - | -$0.49 | - |
EPS (Diluted) | -$0.59 | -$0.69 | - | -$0.49 | - |
EBIT | -$21.97M | -$15.41M | -$13.63M | -$7.42M | - |
EBITDA | -$21.63M | -$15.09M | -$13.41M | -$7.3M | - |